首页> 外文期刊>Chinese Medical Journal >Investigation of the measurement of murine airway hyperres- ponsiveness and the therapeutic effects of budesonide on ovalbumin sensitized and challenged mice
【24h】

Investigation of the measurement of murine airway hyperres- ponsiveness and the therapeutic effects of budesonide on ovalbumin sensitized and challenged mice

机译:小鼠气道高反应性的测定以及布地奈德对卵清蛋白致敏和攻击小鼠的治疗作用的研究

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

Background Airway hyperresponsiveness (AHR) is one of the most important characteristics of asthma. This study investigated the parameters, by which assess the airway responsiveness under tidal ventilation. Methods Female BALB/c mice were sensitized and challenged with ovalbumin (OVA) (group A) , and part of them were treated with budesonide aerosol (group B). All the mice were anaesthetized and mechanically ventilated. The values of tidal volume (V_t) , airway pressure (P_A) , airway flow (F) , expiratory lung resistance ( R_L) and dynamic compliance of the thorax and lung (C_(T-L)) were recorded by the AniRes2003 animal lung function system. In addition, the expiratory volume in the first 0.1 second after the start of expiration (EV_(0.1)) was obtained according to the flow-volume (F-V) curve. The maximal or minimal values of EV_(0.1), R_L and C_(T-L) were documented after each dose of methacholine ( MCH) and compared with values from negative control group (group C ). Results (1) When the dose of MCH reached 100 ng/g or 200 ng/g, the decrease of V_t in group A was much more significant than group C (P =0.001, <0.001 respectively) , but not so between groups B and group C (P = 0.974, 0.362 respectively). (2) With the dose of 25, 50, 100 or 200 ng/g MCH, the decrease in percentage of EV_(0.1) in group A was much higher than group C (P - 0.012, 0.025, 0.001, 0.003 respectively) , while that in group B showed no significant difference as compared with group C ( P = 0.507, 0.896, 0.972, 0.785). (3) R_L and C_(T-L): with the dose of 200 ng/g MCH, there was a statistically significant increase of R_L in group A compared to group B or group C ( P < 0.001, < 0.001 respectively) , but no significant difference between groups B and C (P =0.266). With doses of 100 ng/g and 200 ng/g MCH, there was a statistically significant decrease of C_(T-L) in group A compared to group B (P =0.001, = 0.001) and group C (P< 0.001, < 0.001 respectively) , but no significant difference between groups B and C (P =0.775, 0.310). (4) Histopathology; there were eosinophilic predominant peribronchial and perivascular inflammatory influx in murine lungs after OVA sensitizing and challenging, which could be counteracted by inhalation of budesonide in group B. Conclusions The decline in EV_(0.1) in response to MCH challenge correlated with simultaneous changes in V_t, R_L and C_(T-L), but more sensitively than all the other parameters. The decline in EV_(0.1) and inflammation in murine lung could be significantly alleviated by inhalation of nebulized budesonide solution, which indicated that EV_(0.1) to MCH is a valid measure of AHR in mice.
机译:背景气道高反应性(AHR)是哮喘的最重要特征之一。这项研究调查了参数,通过这些参数可以评估潮气通气下的气道反应性。方法对雌性BALB / c小鼠进行卵白蛋白(OVA)致敏和攻击(A组),部分给予布地奈德气雾剂(B组)治疗。将所有小鼠麻醉并机械通气。 AniRes2003动物肺功能系统记录了潮气量(V_t),气道压力(P_A),气道流量(F),呼气肺阻力(R_L)和胸,肺动态顺应性(C_(TL))的值。另外,根据流量(F-V)曲线获得呼气开始后的前0.1秒的呼气量(EV_(0.1))。每次服用乙酰甲胆碱(MCH)后,记录EV_(0.1),R_L和C_(T-L)的最大值或最小值,并与阴性对照组(C组)的值进行比较。结果(1)当MCH剂量达到100 ng / g或200 ng / g时,A组的V_t降低比C组显着(P分别为0.001,<0.001),而B组之间则没有和C组(分别为P = 0.974、0.362)。 (2)以25、50、100或200 ng / g MCH的剂量,A组的EV_(0.1)百分比降低远高于C组(分别为P-0.012、0.025、0.001、0.003),而B组与C组相比则无显着性差异(P = 0.507、0.896、0.972、0.785)。 (3)R_L和C_(TL):以200 ng / g MCH的剂量,与B组或C组相比,A组的R_L统计学上显着增加(分别为P <0.001,<0.001),但没有B组和C组之间的显着差异(P = 0.266)。在100 ng / g和200 ng / g MCH的剂量下,与B组(P = 0.001,= 0.001)和C组(P <0.001,<0.001)相比,A组的C_(TL)有统计学意义的降低),但B组和C组之间没有显着差异(P = 0.775,0.310)。 (4)组织病理学;在OVA致敏和刺激后,鼠肺中出现了嗜酸性支气管支气管和血管周炎性大量涌入,这可以通过B组吸入布地奈德来抵消。结论MCH激发引起的EV_(0.1)下降与V_t的同时变化相关, R_L和C_(TL),但比所有其他参数敏感。吸入雾化的布地奈德溶液可以明显减轻鼠肺中EV_(0.1)的下降和炎症,这表明EV_(0.1)对MCH的治疗是对小鼠AHR的有效测量。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号